{"DataElement":{"publicId":"2635497","version":"1","preferredName":"Acute Graft Versus Host Disease Liver Involvement Maximum Grade","preferredDefinition":"the maximum grade or stage of severity of acute graft versus host disease, a syndrome of immologically mediated tissue damage occurring following allogeneic transplant affecting the liver, a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile, with onset is usually within one hundred days of transplantation or immunologic manipulation.","longName":"AGVHD_L_INVLT_MAX_GD","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2635448","version":"1","preferredName":"Acute Graft Versus Host Disease Liver Involvement","preferredDefinition":"information related to the acute graft versus host disease, a syndrome of immologically mediated tissue damage occurring following allogeneic transplant affecting the liver, a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile, with onset is usually within one hundred days of transplantation or immunologic manipulation.","longName":"AGVHD_L_INVLT","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512823","version":"1","preferredName":"Acute Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing within the first 100 days post-transplant, but with short duration.","longName":"C4980","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898438-B0B8-35BB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2635446","version":"1","preferredName":"Liver Involvement","preferredDefinition":"A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.:To have a connection by participation or association or use; sharing in an activity or process.","longName":"C12392:C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F7FC5D6-446F-6E9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F7FC5D6-4480-6E9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2635475","version":"1","preferredName":"Acute Graft Versus Host Disease Liver Maximum Grade","preferredDefinition":"The largest possible scale of intensity of acute graft versus host disease involving the liver.","longName":"AGVHD_L_MAX_GD","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 0","valueDescription":"Bilirubin <2.0 mg/dl","ValueMeaning":{"publicId":"2635498","version":"1","preferredName":"Bilirubin <2.0 mg/dl","longName":"2635498","preferredDefinition":"Bilirubin <2.0 mg/dl","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F827974-BB75-1CE8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F82582D-92F8-19D1-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Bilirubin 2-3 mg/dL","ValueMeaning":{"publicId":"2635499","version":"1","preferredName":"Bilirubin 2-3 mg/dL","longName":"2635499","preferredDefinition":"Bilirubin 2-3 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F826922-E879-1A55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F82582D-930A-19D1-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Bilirubin 3-6 mg/dL","ValueMeaning":{"publicId":"2635500","version":"1","preferredName":"Bilirubin 3-6 mg/dL","longName":"2635500","preferredDefinition":"Bilirubin 3-6 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F827E51-019B-19CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F82582D-931C-19D1-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Bilirubin 6-15 mg/dL","ValueMeaning":{"publicId":"2635501","version":"1","preferredName":"Bilirubin 6-15 mg/dL","longName":"2635501","preferredDefinition":"Bilirubin 6-15 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F826416-C7AA-19C9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F82582D-932E-19D1-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"Bilirubin >15 mg/dL","ValueMeaning":{"publicId":"2635502","version":"1","preferredName":"Bilirubin >15 mg/dL","longName":"2635502","preferredDefinition":"Bilirubin >15 mg/dL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F826641-34E3-1B2B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F82582D-9340-19D1-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2635467","version":"1","preferredName":"Maximum Grade","preferredDefinition":"the largest possible quantity or degree.:A position on a scale of intensity or amount or quality.","longName":"C25564:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maximum","conceptCode":"C25564","definition":"The largest possible quantity or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F7FEB1F-64AC-7116-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F813B97-CCAC-03CA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"CAMPBELB","dateModified":"2016-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"AcuteGVHDLiverSTAGE","type":"COG Form Element","context":"CTEP"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Maximum Stage of GVHD of the","type":"Preferred Question Text","description":"Maximum Stage of GVHD of the Liver","url":null,"context":"NHLBI"},{"name":"CRF Text","type":"Alternate Question Text","description":"Liver Abnormality","url":null,"context":"NHLBI"},{"name":"CRF TEXT","type":"Alternate Question Text","description":"Stage of acute GVHD of the Liver:","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What is patients maximum stage of GvHD?","url":null,"context":"COG"}],"origin":"Transplant CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F8272B5-3ECE-1C53-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"KUMMEROA","dateModified":"2021-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}